1. Leiter H et al. Microbicidal activity of N-chlorotaurine can be enhanced in the presence of lung epithelial cells. J Cyst Fibros. 2020; 19(6): 1011-1017.
  2. Teuchner B et al. N-chlorotaurine Inactivates Acanthamoeba and Candida albicans in the Porcine Ex Vivo Corneal Infection Model. Cornea. 2019; 38(8): 1011-1016.
  3. Sheehan G et al. ​Exposure to N-chlorotaurine induces oxidative stress responses in Aspergillus fumigatusJ Med Microbiology. 2019; 68: 279-288.
  4. Nagl M et al. N-Chlorotaurine, a Promising Future Candidate for Topical Therapy of Fungal Infections. Mycopathologia. 2018; 183: 161-170.
  5. Gruber M et al. Bactericidal and Fungicidal Activity of N-Chlorotaurine Is Enhanced in Cystic Fibrosis Sputum Medium. Antimicrob Agents Chemother. 2017; 61(5): e02527-16.
  6. Lackner M et al. N-Chlorotaurine Exhibits Fungicidal Activity against Therapy-Refractory Scedosporium Species and Lomentospora prolificans. Antimicrob Agents Chemother. 2015; 59(10): 6454-6462.
  7. Neher A et al. Antimicrobial activity of dexamethasone and its combination with N-chlorotaurine. Arch Otolaryngol Head Neck Surg. 2008; 134(6): 615-620.
  8. Nagl M et al. Impact of N-chlorotaurine on viability and production of secreted aspartyl proteinases of Candida spp. Antimicrob Agents Chemother. 2002; 46(6): 1996-1999.
  9. Nagl M et al. Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother. 2001; 47(6): 871-874.